Hsa-LINC02418/mmu-4930573I07Rik regulated by METTL3 dictates anti-PD-L1 immunotherapeutic efficacy via enhancement of Trim21-mediated PD-L1 ubiquitination.
Sun Z, Mai H, Xue C, Fan Z, Li J, Chen H, Huo N, Kang X, Tang C, Fang L, Zhao H, Han Y, Sun C, Peng H, Du Y, Yang J, Du N, Xu X.
Sun Z, et al. Among authors: sun c.
J Immunother Cancer. 2023 Dec 1;11(12):e007415. doi: 10.1136/jitc-2023-007415.
J Immunother Cancer. 2023.
PMID: 38040417
Free PMC article.